Abvc Biopharma (ABVC) Accumulated Depreciation (2010 - 2026)
Abvc Biopharma's Accumulated Depreciation came in at $3.39 million for Q2 2026, down 0.1% from $3.39 million a year earlier but up 0.2% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Accumulated Depreciation (2010 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma's Accumulated Depreciation was $3.38 million, up 1.1% from FY2024.
- Accumulated Depreciation has increased in each of the last three years, with a three-year compound annual growth rate of 0.8% (FY2022 to FY2025).
- Going back by year, Accumulated Depreciation was $3.34 million in FY2024 (+0.2%), $3.34 million in FY2023 (+0.9%) and $3.3 million in FY2022.
- The five-year range for quarterly Accumulated Depreciation is $3.3 million (Q4 2022) to $3.39 million (Q2 2025).
- Year-over-year, Accumulated Depreciation increased in six of the last seven quarters, with growth averaging 0.9%.
- The fastest year-over-year change in Accumulated Depreciation over five years came in Q2 2025 (growth of 1.8%), and the weakest in Q2 2026 (a decline of 0.1%).
- Business Quant data shows ABVC's Accumulated Depreciation at $3.38 million (Q1 2026), $3.38 million (Q4 2025) and $3.38 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.39 Mn |
| Mar 31, 2026 | 3.38 Mn |
| Dec 31, 2025 | 3.38 Mn |
| Sep 30, 2025 | 3.38 Mn |
| Jun 30, 2025 | 3.39 Mn |
| Mar 31, 2025 | 3.34 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | 3.33 Mn |
| Mar 31, 2024 | 3.32 Mn |
| Dec 31, 2023 | 3.34 Mn |
| Dec 31, 2022 | 3.30 Mn |
| Mar 31, 2020 | 3.25 Mn |
| Dec 31, 2019 | 3.24 Mn |
| Jun 30, 2012 | 99,887.00 |
| Mar 31, 2012 | -96,685.00 |
| Dec 31, 2011 | -93,426.00 |
| Sep 30, 2011 | 89,837.00 |
| Jun 30, 2011 | -86,059.00 |
| Sep 30, 2010 | -74,756.00 |
API Access
Abvc Biopharma Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();